background fortune rabbit
Renowned journalist and editor-in-chief of the New Crusading Guide , Abdul Malik Kweku Baako Jnr., has publicly declared his support for the New Patriotic Party (NPP) ahead of the December 7 general elections. In a passionate message shared on social media, Baako creatively tied his surname to the party’s position on the ballot, urging Ghanaians to cast their votes for the NPP. “My name is BAAKO. I will vote for Number ONE (BAAKO) on the Presidential Ballot on December 7th! I appeal to the good people of Ghana to do the same! I pray Number ONE (BAAKO) triumphs. FINGERS CROSSED!” he wrote, expressing hope for a victory that aligns with his vision for the country’s future. Acknowledging the expected backlash from his public endorsement, Baako remained undeterred, expressing his readiness to face any criticism. “I know the usual suspects would come raining insults and threaten brimstone and fire here! I will tolerate their predictably robotic character assassinations and personality attacks. Blocking is alien to my political and communication DNA!” he said, maintaining his stance despite the anticipated vitriol. Baako, known for his resilience in the face of adversity, reaffirmed his commitment to free speech, a cornerstone of democracy. “I have the shock absorbers to contain their legendary nuisance! Their political antecedents did worse to me. All I would say is that FREE SPEECH is not a CRIME!” he concluded, addressing potential detractors with a defiant call for the protection of democratic expression.The trouble began when the couple received a flyer advertising a 9.9 special one-day tour package to a nearby tourist destination. Seduced by the attractive price and promises of a luxurious experience, they decided to take advantage of the offer. Little did they know that they were about to be ensnared in a web of deception.As the investigation unfolds and more information comes to light, one can only hope that swift action will be taken to address the underlying issues that led to this alarming outbreak of illnesses. In the meantime, vigilance and caution are paramount, as the community grapples with the aftermath of this disturbing incident at the newly established bathhouse.
In conclusion, the announcement by the Chinese Ministry of National Defense regarding the restriction of coastal airspace underscores China's commitment to safeguarding its national security and territorial integrity. The response from the Chinese Ministry of Foreign Affairs reaffirms China's determination to uphold its sovereignty and contribute to regional peace and stability. It is imperative for all parties to approach this issue with a spirit of cooperation and dialogue in order to achieve mutually beneficial outcomes for all.In conclusion, as the tech investment landscape continues to evolve, the rise of patient capital as exemplified by funds like XYZ Fund represents a significant paradigm shift in the way investments are made and valued. By prioritizing long-term growth and sustainability, these funds are not only driving innovation and transformation in the tech industry but also setting a new standard for responsible and impactful investing. As we look to the future, it is clear that patient capital will play an increasingly crucial role in shaping the next generation of tech pioneers and disruptors.
Sam Darnold leads game-winning drive in OT and Vikings beat Bears 30-27 after blowing late lead
In addition to its attractive location and development potential, the land parcel in Fengtai District also benefits from a favorable policy environment that supports sustainable and innovative urban development. With the Chinese government's push for urban renewal and the promotion of green and smart city initiatives, the winning bidder will have the opportunity to showcase their commitment to sustainable development and urban planning.As individuals navigate the complexities of the modern job market, it is essential to draw inspiration from Zhang Chaoyang's words of wisdom. Instead of viewing age as a barrier, professionals should embrace their experience and harness it as a source of strength. By demonstrating resilience, adaptability, and a willingness to learn and evolve, individuals can defy stereotypes and showcase the unique contributions they bring to the table.
Indianapolis Colts coach Shane Steichen seemed to sense the question might arise after his club was eliminated from playoff consideration Sunday with a ghastly 45-33 loss to the host New York Giants in East Rutheford, N.J. The Giants were 2-13 and had lost a franchise-record 10 straight games entering the contest and their season-high point total Sunday more than tripled their season average of 14.3 points per game. It was the type of bad loss that leads to head coaches being asked about their job security. "I control what I can control," Steichen said of the employment situation. The Colts (7-9) were outplayed all contest by the team that entered the day with the worst record in the NFL -- and with their playoff hopes on the line. Last season, Steichen's first as Indianapolis coach, the Colts also fell short, losing to the Houston Texans in the final week of the season to miss the playoffs. "It was as disappointing as it gets," Steichen said of the setback against the Giants. "As the leader of a football team, shoot, I always say I've got to be better, we've all got to be better. That's a group effort, everyone's got to chip in and do their part, so stuff like that doesn't happen." Giants quarterback Drew Lock passed for 309 yards and tied his career high of four touchdowns while also running for a score. Meanwhile, the Colts also went with a reserve quarterback in veteran Joe Flacco and he turned the ball over three times on two interceptions and a fumble. He also passed for 330 yards. Flacco started because rookie Anthony Richardson couldn't play due to back and foot injuries. Indianapolis completes the season next weekend at home against the Jacksonville Jaguars. "I know it's a tough situation, obviously, when you're out of the playoff hunt, but again, I told (the team) we've got to be professional about it," Steichen said. "That's the biggest thing. We've got to show up and do our job still with one week left." The Colts last made the playoffs in the 2020 season. Their last playoff win was two seasons earlier. --Field Level MediaIn a surprising turn of events, the popular mobile game "Phantasmal Beast Paru" has recently announced a major update that is causing a stir among players. The update, which is set to remove the throwing of Poké Balls as a summoning mechanism for capturing creatures, has sparked controversy and debate within the game's community.
After his team's 102-89 home win on Wednesday night over Purdue Fort Wayne, Penn State coach Mike Rhoades challenged his team's fan base to show up and make more noise. "Sweat with us," he said at one point. At 5-0, the Nittany Lions haven't had to sweat much to get off to a fast start. They might not have to expend much perspiration to make it 6-0 on Monday when they meet Fordham in a semifinal matchup at the Sunshine Slam tournament in Daytona Beach, Fla. Penn State hasn't played a strong schedule so far, but the team has been impressive. It's averaging 98.2 points per game and 13.8 steals per game, both of which ranked second in Division I through Saturday's play. The Nittany Lions were seventh per kenpom.com in turnover rate, forcing 25.3 per 100 possessions. Point guard Ace Baldwin Jr. is leading the charge, scoring 16.4 points and dishing out 7.8 assists while chipping in 2.6 steals. Zach Hicks has nearly doubled his scoring average from 8.4 last season to 15.8 this season, while Northern Illinois transfer Yanic Konan Niederhauser has beefed up the interior, tallying 12.2 points and 7.2 rebounds. Meanwhile, Fordham (3-3) is coming off a 73-71 home loss Friday night against Drexel in New York. The Rams blew a seven-point lead early in the second half and missed a chance to force overtime when leading scorer Jackie Johnson III missed a layup as time expired. Johnson, a UNLV transfer, is averaging 19 points per game and is making nearly 48 percent of his shots as one of three Rams with double-figure scoring averages. Jahmere Tripp scores at an 11.0 clip while Japhet Medor is contributed 10.5, but Fordham is struggling to make shots, canning only 41.5 percent from the field. The Rams were picked for a 14th-place finish in the Atlantic 10 despite returning more scoring than any team in the league except for VCU. Third-year coach Keith Urgo thinks his team can defy low external expectations. "We're experienced and I think we're poised to have a tremendous year," he said. --Field Level MediaGerman Consulate Hosts Unity Day In Lagos as Diplomatic Ties Bloom
StockNews.com started coverage on shares of Syros Pharmaceuticals ( NASDAQ:SYRS – Free Report ) in a report released on Thursday. The brokerage issued a sell rating on the stock. Other equities research analysts have also issued research reports about the company. Brookline Capital Management reissued a “hold” rating on shares of Syros Pharmaceuticals in a research note on Wednesday, November 13th. JMP Securities reiterated a “market perform” rating on shares of Syros Pharmaceuticals in a research report on Wednesday, November 13th. HC Wainwright restated a “neutral” rating and issued a $1.00 price target (down previously from $6.00) on shares of Syros Pharmaceuticals in a research report on Wednesday, November 13th. Piper Sandler reiterated an “overweight” rating and issued a $5.00 price objective (down from $13.00) on shares of Syros Pharmaceuticals in a research report on Tuesday, August 13th. Finally, TD Cowen restated a “hold” rating on shares of Syros Pharmaceuticals in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $3.33. Check Out Our Latest Stock Analysis on Syros Pharmaceuticals Syros Pharmaceuticals Stock Performance Syros Pharmaceuticals ( NASDAQ:SYRS – Get Free Report ) last announced its quarterly earnings data on Thursday, October 31st. The company reported ($0.68) EPS for the quarter, beating the consensus estimate of ($0.76) by $0.08. During the same quarter last year, the firm posted ($1.35) earnings per share. On average, sell-side analysts predict that Syros Pharmaceuticals will post -2.94 earnings per share for the current year. Insider Transactions at Syros Pharmaceuticals In other news, CEO Conley Chee bought 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were purchased at an average price of $1.51 per share, for a total transaction of $75,500.00. Following the completion of the transaction, the chief executive officer now owns 72,504 shares in the company, valued at $109,481.04. The trade was a 222.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link . Also, CFO Jason Haas purchased 45,344 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $1.68 per share, with a total value of $76,177.92. Following the completion of the acquisition, the chief financial officer now directly owns 124,552 shares in the company, valued at $209,247.36. The trade was a 57.25 % increase in their position. The disclosure for this purchase can be found here . Insiders purchased a total of 130,707 shares of company stock valued at $206,491 over the last three months. 12.26% of the stock is currently owned by insiders. Institutional Inflows and Outflows Several institutional investors have recently bought and sold shares of SYRS. Opaleye Management Inc. raised its holdings in Syros Pharmaceuticals by 119.1% in the 1st quarter. Opaleye Management Inc. now owns 787,545 shares of the company’s stock valued at $4,213,000 after acquiring an additional 428,175 shares during the last quarter. Kennedy Capital Management LLC acquired a new position in Syros Pharmaceuticals in the 1st quarter valued at $2,166,000. Vanguard Group Inc. raised its holdings in Syros Pharmaceuticals by 21.3% in the 1st quarter. Vanguard Group Inc. now owns 928,046 shares of the company’s stock valued at $4,965,000 after acquiring an additional 163,234 shares during the last quarter. Certuity LLC acquired a new position in Syros Pharmaceuticals in the 2nd quarter valued at $109,000. Finally, Acadian Asset Management LLC raised its holdings in Syros Pharmaceuticals by 101.5% in the 2nd quarter. Acadian Asset Management LLC now owns 34,578 shares of the company’s stock valued at $178,000 after acquiring an additional 17,416 shares during the last quarter. 91.47% of the stock is currently owned by institutional investors and hedge funds. Syros Pharmaceuticals Company Profile ( Get Free Report ) Syros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. Read More Receive News & Ratings for Syros Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syros Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .Despite playing primarily as a central defender, Koundé's versatility and attacking flair have caught the attention of his teammates as well. Captain Sergio Ramos commended Koundé's shooting prowess, stating, "Jules is a natural goal-scorer. His ability to strike the ball cleanly and accurately is a valuable asset to our team. He adds a new dimension to our attacking options."
Renowned journalist and editor-in-chief of the New Crusading Guide , Abdul Malik Kweku Baako Jnr., has publicly declared his support for the New Patriotic Party (NPP) ahead of the December 7 general elections. In a passionate message shared on social media, Baako creatively tied his surname to the party’s position on the ballot, urging Ghanaians to cast their votes for the NPP. “My name is BAAKO. I will vote for Number ONE (BAAKO) on the Presidential Ballot on December 7th! I appeal to the good people of Ghana to do the same! I pray Number ONE (BAAKO) triumphs. FINGERS CROSSED!” he wrote, expressing hope for a victory that aligns with his vision for the country’s future. Acknowledging the expected backlash from his public endorsement, Baako remained undeterred, expressing his readiness to face any criticism. “I know the usual suspects would come raining insults and threaten brimstone and fire here! I will tolerate their predictably robotic character assassinations and personality attacks. Blocking is alien to my political and communication DNA!” he said, maintaining his stance despite the anticipated vitriol. Baako, known for his resilience in the face of adversity, reaffirmed his commitment to free speech, a cornerstone of democracy. “I have the shock absorbers to contain their legendary nuisance! Their political antecedents did worse to me. All I would say is that FREE SPEECH is not a CRIME!” he concluded, addressing potential detractors with a defiant call for the protection of democratic expression.The trouble began when the couple received a flyer advertising a 9.9 special one-day tour package to a nearby tourist destination. Seduced by the attractive price and promises of a luxurious experience, they decided to take advantage of the offer. Little did they know that they were about to be ensnared in a web of deception.As the investigation unfolds and more information comes to light, one can only hope that swift action will be taken to address the underlying issues that led to this alarming outbreak of illnesses. In the meantime, vigilance and caution are paramount, as the community grapples with the aftermath of this disturbing incident at the newly established bathhouse.
In conclusion, the announcement by the Chinese Ministry of National Defense regarding the restriction of coastal airspace underscores China's commitment to safeguarding its national security and territorial integrity. The response from the Chinese Ministry of Foreign Affairs reaffirms China's determination to uphold its sovereignty and contribute to regional peace and stability. It is imperative for all parties to approach this issue with a spirit of cooperation and dialogue in order to achieve mutually beneficial outcomes for all.In conclusion, as the tech investment landscape continues to evolve, the rise of patient capital as exemplified by funds like XYZ Fund represents a significant paradigm shift in the way investments are made and valued. By prioritizing long-term growth and sustainability, these funds are not only driving innovation and transformation in the tech industry but also setting a new standard for responsible and impactful investing. As we look to the future, it is clear that patient capital will play an increasingly crucial role in shaping the next generation of tech pioneers and disruptors.
Sam Darnold leads game-winning drive in OT and Vikings beat Bears 30-27 after blowing late lead
In addition to its attractive location and development potential, the land parcel in Fengtai District also benefits from a favorable policy environment that supports sustainable and innovative urban development. With the Chinese government's push for urban renewal and the promotion of green and smart city initiatives, the winning bidder will have the opportunity to showcase their commitment to sustainable development and urban planning.As individuals navigate the complexities of the modern job market, it is essential to draw inspiration from Zhang Chaoyang's words of wisdom. Instead of viewing age as a barrier, professionals should embrace their experience and harness it as a source of strength. By demonstrating resilience, adaptability, and a willingness to learn and evolve, individuals can defy stereotypes and showcase the unique contributions they bring to the table.
Indianapolis Colts coach Shane Steichen seemed to sense the question might arise after his club was eliminated from playoff consideration Sunday with a ghastly 45-33 loss to the host New York Giants in East Rutheford, N.J. The Giants were 2-13 and had lost a franchise-record 10 straight games entering the contest and their season-high point total Sunday more than tripled their season average of 14.3 points per game. It was the type of bad loss that leads to head coaches being asked about their job security. "I control what I can control," Steichen said of the employment situation. The Colts (7-9) were outplayed all contest by the team that entered the day with the worst record in the NFL -- and with their playoff hopes on the line. Last season, Steichen's first as Indianapolis coach, the Colts also fell short, losing to the Houston Texans in the final week of the season to miss the playoffs. "It was as disappointing as it gets," Steichen said of the setback against the Giants. "As the leader of a football team, shoot, I always say I've got to be better, we've all got to be better. That's a group effort, everyone's got to chip in and do their part, so stuff like that doesn't happen." Giants quarterback Drew Lock passed for 309 yards and tied his career high of four touchdowns while also running for a score. Meanwhile, the Colts also went with a reserve quarterback in veteran Joe Flacco and he turned the ball over three times on two interceptions and a fumble. He also passed for 330 yards. Flacco started because rookie Anthony Richardson couldn't play due to back and foot injuries. Indianapolis completes the season next weekend at home against the Jacksonville Jaguars. "I know it's a tough situation, obviously, when you're out of the playoff hunt, but again, I told (the team) we've got to be professional about it," Steichen said. "That's the biggest thing. We've got to show up and do our job still with one week left." The Colts last made the playoffs in the 2020 season. Their last playoff win was two seasons earlier. --Field Level MediaIn a surprising turn of events, the popular mobile game "Phantasmal Beast Paru" has recently announced a major update that is causing a stir among players. The update, which is set to remove the throwing of Poké Balls as a summoning mechanism for capturing creatures, has sparked controversy and debate within the game's community.
After his team's 102-89 home win on Wednesday night over Purdue Fort Wayne, Penn State coach Mike Rhoades challenged his team's fan base to show up and make more noise. "Sweat with us," he said at one point. At 5-0, the Nittany Lions haven't had to sweat much to get off to a fast start. They might not have to expend much perspiration to make it 6-0 on Monday when they meet Fordham in a semifinal matchup at the Sunshine Slam tournament in Daytona Beach, Fla. Penn State hasn't played a strong schedule so far, but the team has been impressive. It's averaging 98.2 points per game and 13.8 steals per game, both of which ranked second in Division I through Saturday's play. The Nittany Lions were seventh per kenpom.com in turnover rate, forcing 25.3 per 100 possessions. Point guard Ace Baldwin Jr. is leading the charge, scoring 16.4 points and dishing out 7.8 assists while chipping in 2.6 steals. Zach Hicks has nearly doubled his scoring average from 8.4 last season to 15.8 this season, while Northern Illinois transfer Yanic Konan Niederhauser has beefed up the interior, tallying 12.2 points and 7.2 rebounds. Meanwhile, Fordham (3-3) is coming off a 73-71 home loss Friday night against Drexel in New York. The Rams blew a seven-point lead early in the second half and missed a chance to force overtime when leading scorer Jackie Johnson III missed a layup as time expired. Johnson, a UNLV transfer, is averaging 19 points per game and is making nearly 48 percent of his shots as one of three Rams with double-figure scoring averages. Jahmere Tripp scores at an 11.0 clip while Japhet Medor is contributed 10.5, but Fordham is struggling to make shots, canning only 41.5 percent from the field. The Rams were picked for a 14th-place finish in the Atlantic 10 despite returning more scoring than any team in the league except for VCU. Third-year coach Keith Urgo thinks his team can defy low external expectations. "We're experienced and I think we're poised to have a tremendous year," he said. --Field Level MediaGerman Consulate Hosts Unity Day In Lagos as Diplomatic Ties Bloom
StockNews.com started coverage on shares of Syros Pharmaceuticals ( NASDAQ:SYRS – Free Report ) in a report released on Thursday. The brokerage issued a sell rating on the stock. Other equities research analysts have also issued research reports about the company. Brookline Capital Management reissued a “hold” rating on shares of Syros Pharmaceuticals in a research note on Wednesday, November 13th. JMP Securities reiterated a “market perform” rating on shares of Syros Pharmaceuticals in a research report on Wednesday, November 13th. HC Wainwright restated a “neutral” rating and issued a $1.00 price target (down previously from $6.00) on shares of Syros Pharmaceuticals in a research report on Wednesday, November 13th. Piper Sandler reiterated an “overweight” rating and issued a $5.00 price objective (down from $13.00) on shares of Syros Pharmaceuticals in a research report on Tuesday, August 13th. Finally, TD Cowen restated a “hold” rating on shares of Syros Pharmaceuticals in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $3.33. Check Out Our Latest Stock Analysis on Syros Pharmaceuticals Syros Pharmaceuticals Stock Performance Syros Pharmaceuticals ( NASDAQ:SYRS – Get Free Report ) last announced its quarterly earnings data on Thursday, October 31st. The company reported ($0.68) EPS for the quarter, beating the consensus estimate of ($0.76) by $0.08. During the same quarter last year, the firm posted ($1.35) earnings per share. On average, sell-side analysts predict that Syros Pharmaceuticals will post -2.94 earnings per share for the current year. Insider Transactions at Syros Pharmaceuticals In other news, CEO Conley Chee bought 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were purchased at an average price of $1.51 per share, for a total transaction of $75,500.00. Following the completion of the transaction, the chief executive officer now owns 72,504 shares in the company, valued at $109,481.04. The trade was a 222.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link . Also, CFO Jason Haas purchased 45,344 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $1.68 per share, with a total value of $76,177.92. Following the completion of the acquisition, the chief financial officer now directly owns 124,552 shares in the company, valued at $209,247.36. The trade was a 57.25 % increase in their position. The disclosure for this purchase can be found here . Insiders purchased a total of 130,707 shares of company stock valued at $206,491 over the last three months. 12.26% of the stock is currently owned by insiders. Institutional Inflows and Outflows Several institutional investors have recently bought and sold shares of SYRS. Opaleye Management Inc. raised its holdings in Syros Pharmaceuticals by 119.1% in the 1st quarter. Opaleye Management Inc. now owns 787,545 shares of the company’s stock valued at $4,213,000 after acquiring an additional 428,175 shares during the last quarter. Kennedy Capital Management LLC acquired a new position in Syros Pharmaceuticals in the 1st quarter valued at $2,166,000. Vanguard Group Inc. raised its holdings in Syros Pharmaceuticals by 21.3% in the 1st quarter. Vanguard Group Inc. now owns 928,046 shares of the company’s stock valued at $4,965,000 after acquiring an additional 163,234 shares during the last quarter. Certuity LLC acquired a new position in Syros Pharmaceuticals in the 2nd quarter valued at $109,000. Finally, Acadian Asset Management LLC raised its holdings in Syros Pharmaceuticals by 101.5% in the 2nd quarter. Acadian Asset Management LLC now owns 34,578 shares of the company’s stock valued at $178,000 after acquiring an additional 17,416 shares during the last quarter. 91.47% of the stock is currently owned by institutional investors and hedge funds. Syros Pharmaceuticals Company Profile ( Get Free Report ) Syros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. Read More Receive News & Ratings for Syros Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syros Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .Despite playing primarily as a central defender, Koundé's versatility and attacking flair have caught the attention of his teammates as well. Captain Sergio Ramos commended Koundé's shooting prowess, stating, "Jules is a natural goal-scorer. His ability to strike the ball cleanly and accurately is a valuable asset to our team. He adds a new dimension to our attacking options."